stock setter

$MESO Mesoblast reports RYONCIL 44% net revenue growth for first fiscal quarter -For the quarter ended September 30, 2026, revenue was US$28 million, subject to financial closing procedures and audit. - Operating cash spend fell 86% to US$2.1 million from US$14.9 million a year earlier. - Quarter-end cash was US$99 million. stocktitan.net/news/MESO/act…

$KRMN -RBC lowers Karman target to $60 from $70 Outperform - $KTOS -RBC lowers Kratos Defense target to $55 from $80 Outperform - $KVYO -Citi raises Klaviyo target to $38 from $36 Buy -Wells Fargo raises target to $24 from $22 Overweight

$KO -UBS raises Coca-Cola target to $106 from $104 Buy -Cowen raises target to $104 from $100 Buy -Morgan Stanley raises target to $103 from $100 Overweight -Citi raises target to $103 from $102 Buy -Wells Fargo raises target to $100 from $90 Overweight -JPMorgan raises target to $98 from $95 Overweight -Feedom Broker raises target to $89 from $85 Hold

$KMB -UBS raises Kimberly-Clark target to $113 from $106 Neutral - $KMI -RBC raises Kinder Morgan target to $38 from $36 Sector Perform - $KNSA -Wells Fargo raises Kiniksa Pharmaceuticals target to $110 from $87 Overweight -Wedbush raises target to $102 from $99 Outperform -Goldman raises target to $101 from $90 Buy

$KIDS -Lake Street raises OrthoPediatrics target to $38 from $34 Buy -Needham maintains $35 target Buy -Piper Sandler raises target to $30 from $25 Overweight -Canaccord raises target to $30 from $28 Buy -BTIG raises target to $30 from $29 Buy -Truist raises target to $28 from $22 Buy -Stifel raises target to $27 from $24 Buy

$ITRI -Oppenheimer reiterates Itron $135 target Outperform -JPMorgan raises target to $109 from $107 Overweight -BNP Paribas lowers target to $105 from $115 Outperform - $JAZZ -JPMorgan Jazz Pharmaceuticals target to $300 from $276 Overweight

$INTA -Citi raises Intapp target to $40 from $36 Neutral - $IQV -Truist raises IQVIA target to $346 from $329 Buy -JPMorgan target to $325 from $295 Overweight

$ICLR -Evercore raises ICON target to $240 from $180 Outperform - $INDV -Barclays raises Indivior target to $45 from $43 Overweight - $INIO -Morgan Stanley Innio target to $42 from $40 Overweight -Citi lowers target to $21 from $22 Neutral

$HSY -Evercore raises Hershey target to $225 from $210 Outperform - $HUBB -Baird lowers Hubbell target to $540 from $550 Outperform -Wells Fargo lowers target to $525 from $531 Overweight -Mizuho lowers target to $515 from $560 Outperform -JPMorgan raises target to $486 from $485 Neutral

$HOOD -Citizens JMP reiterates Robinhood $165 target Market Outperform -KeyBanc lowers target to $135 from $140 Overweight -BTIG, Rosenblatt maintain $135 target Buy -Goldman lowers target to $128 from $145 Buy -Truist lowers target to $125 from $134 Buy -Scotiabank lowers target to $124 from $136 Sector Outperform -Needham lowers target to $116 from $126 Buy -Barclays lowers target to $115 from $132 Overweight -JPMorgan lowers target to $114 from $115 Neutral -Wells Fargo lowers target to $100 from $120 = Weight

$HLT -Goldman reiterates Hilton Worldwide $390 target Buy -Wells Fargo raises target to $386 from $383 Overweight -Barclays lowers target to $375 from $384 Overweight -Morgan Stanley raises target to $362 from $349 Overweight -Baird raises target to $362 from $360 Outperform -Susquehanna raises target to $360 from $345 Neutral

$HCA -Bank of America raises HCA Healthcare target to $500 from $450 Buy -Mizuho raises target to $495 from $475 Outperform -KeyBanc raises target to $490 from $435 Overweight -Cowen raises target to $486 from $460 Buy -Baird raises target to $409 from $393 Neutral

$GRAB -JPMorgan lowers Grab target to $4.80 from $5.90 Overweight - $HAS -UBS raises Hasbro target to $137 from $120 Buy - $HAWK -RBC lowers HawkEye 360 target to $21 from $28 Outperform

$GLXY -Canaccord reiterates Galaxy Digital $50 target Buy -HC Wainwright lowers target to $36 from $40 Buy - $GM -Tigress Financial raises General Motors target to $132 from $130 on defense growth -Maintains Strong Buy rating ca.investing.com/news/stock-…

$GLW -UBS lowers Corning target to $192 from $201 Buy -Truist lowers target to $175 from $182 Buy -Morgan Stanley lowers target to $155 from $165 = Weight -Barclays raises target to $132 from $129 = Weight

$GEHC -BRIG raises GE Healthcare target to $83 from $75 Buu - $GERN -Wedbush lowers Geron target to $5 from $6 on study halt Outperform -Needham lowers target to $2.50 from $4 Buy ca.investing.com/news/stock-…

$GERN Geron's Rytelo expansion bid falters in Phase III myelofibrosis trial - Geron discontinues a Phase III trial of Rytelo (imetelstat) in myelofibrosis firstwordpharma.com/story/83… via @fwpharma

$FIG -Citi lowers Figma target to $35 from $37 Buy - $FIVN -Wells Fargo raises Five9 target to $36 from $32 = Weight - $FLYW -Morgan Stanley raises Flywire target to $24 from $22 Overweight - $FROG -Oppenheimer raises JFrog target to $125 from $115 Outperform

$FFIV -RBC raises F5 target to $540 from $525 Outperform -Evercore raises target to $500 from $475 Outperform -Piper Sandler downgrades to Neutral from Overweight Maintains $461 target -Morgan Stanley raises target to $448 from $415 = Weight -Goldman raises target to $435 from $400 Neutral -Barclays raises target to $428 from $397 = Weight